Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer

  • Valentina Rossi, Ivana Sarotto, Furio Maggiorotto, Paola Berchialla, Franziska Kubatzki, Nicoletta Tomasi, Stefania Redana, Rossella Martinello, Giorgio Valabrega, Massimo Aglietta, Riccardo Ponzone, Filippo Montemurro
  • The Oncologist, September 2012, Alphamed Press
  • DOI: 10.1634/theoncologist.2012-0194

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1634/theoncologist.2012-0194

The following have contributed to this page: paola berchialla